CONTRACT 6385/OLEPTRO

Anonymous

Guest
What is eveyone's thought regarding the AL Contract lasting? I realize we work for AL and not just labopharm, however, bad news continues to cause problems for labopharm. Mary Ann, Kate, and Neil are good people and truly want us to succeed? But with limited MCO coverage, limited clinical data, and only 80 targeted customers can we succeed? What are your thoughts? I hope we can...
 






just interviewed in Midwest for this contract. The drug seems like a dog to me. There's a $4 generic competing with it, no managed care coverage, and no real advantages over the generic as far a side effects, right? So WTF? Do they micro-manage with signatures, etc.? What do the docs say about it?
 






It is clear that this contract is just about over. It is a shame this is a good drug with poor internal management. How can you possibly run a company or a saleforce for that matter and have no live customer interaction with either your internal or external customers. Take this time to start looking. The news has been reporting this downfall for months and now they are finally admitting it.